These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8833563)

  • 21. Cortical hyperostosis secondary to prolonged use of prostaglandin E1.
    de Almeida JF; Kimura H; Hercowitz LH; Korkes H; Troster EJ
    Clinics (Sao Paulo); 2007 Jun; 62(3):363-6. PubMed ID: 17589681
    [No Abstract]   [Full Text] [Related]  

  • 22. Gastric-outlet obstruction induced by prostaglandin therapy in neonates.
    Peled N; Dagan O; Babyn P; Silver MM; Barker G; Hellmann J; Scolnik D; Koren G
    N Engl J Med; 1992 Aug; 327(8):505-10. PubMed ID: 1635565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute profound thrombocytopenia following abciximab therapy.
    Bishara AI; Hagmeyer KO
    Ann Pharmacother; 2000; 34(7-8):924-30. PubMed ID: 10928405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evidence-based medicine: labor induction with prostaglandins].
    Winkler M; Rath W
    Z Geburtshilfe Neonatol; 1999 Dec; 203 Suppl 2():6-11. PubMed ID: 10612191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocytosis caused by prostaglandin E1 in neonates.
    Arav-Boger R; Baggett HC; Spevak PJ; Willoughby RE
    J Pediatr; 2001 Feb; 138(2):263-5. PubMed ID: 11174627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ['Labor storm' following cervical ripening with prostaglandin gel].
    van Gestel I; Roumen FJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):161-4. PubMed ID: 9557019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin induction of labour.
    Dickson MJ; Pandiarajan T
    J Obstet Gynaecol; 2003 Mar; 23(2):215. PubMed ID: 12745574
    [No Abstract]   [Full Text] [Related]  

  • 28. Cortical hyperostosis secondary to prostaglandin E1 therapy.
    Estes K; Nowicki M; Bishop P
    J Pediatr; 2007 Oct; 151(4):441, 441.e1. PubMed ID: 17889087
    [No Abstract]   [Full Text] [Related]  

  • 29. [Risk in labor induction with prostaglandin E2 administered intracervically].
    Binder T; Zivný J
    Ceska Gynekol; 1997 Dec; 62 Suppl():43-6. PubMed ID: 9601721
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostaglandin E2 induction of labor for isolated oligohydramnios in women with unfavorable cervix at term.
    Danon D; Ben-Haroush A; Yogev Y; Bar J; Hod M; Pardo J
    Fetal Diagn Ther; 2007; 22(1):75-9. PubMed ID: 17003561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
    Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
    J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The harlequin color change and association with prostaglandin E1.
    Rao J; Campbell ME; Krol A
    Pediatr Dermatol; 2004; 21(5):573-6. PubMed ID: 15461766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dinoprostone vaginal pessary for induction of labour: safety of use for up to 24 h.
    Tathem K; Harris LJ; O'Rourke P; Kimble RM
    Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):582-7. PubMed ID: 23004009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Uterine hyperstimulation following cervix ripening with dinoprostone in a vaginal insert system].
    Brouwers JM; Briët JW; Brouwers JR
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1300-3. PubMed ID: 15279216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin-induced cortical hyperostosis. Case report and review of the literature.
    Gardiner JS; Zauk AM; Donchey SS; McInerney VK
    J Bone Joint Surg Am; 1995 Jun; 77(6):932-6. PubMed ID: 7782366
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cortical hyperostoses after long-term prostaglandin E2 therapy].
    Benz-Bohm G; Emons D; Schickendantz S; Mallmann R; Redel D; Knöpfle G; Mennicken U
    Radiologe; 1984 Feb; 24(2):72-8. PubMed ID: 6369389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of intravaginal and two intracervical prostaglandin E2 gels in pre-induction of labour.
    Ekblad U; Erkkola R; Pirhonen J
    Ann Chir Gynaecol Suppl; 1994; 208():64-7. PubMed ID: 8092777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E1 treatment in ductus dependent congenital cardiac malformation. A review of the treatment of 34 neonates.
    Høst A; Halken S; Kamper J; Lillquist K
    Dan Med Bull; 1988 Feb; 35(1):81-4. PubMed ID: 3342648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine rupture after use of a prostaglandin E2 vaginal insert during vaginal birth after cesarean. A report of two cases.
    Raskin KS; Dachauer JD; Doeden AL; Rayburn WF
    J Reprod Med; 1999 Jun; 44(6):571-4. PubMed ID: 10394556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retention of dinoprostone vaginal insert beyond 12 hours for induction of labor.
    Brennan MC; Pevzner L; Wing DA; Powers BL; Rayburn WF
    Am J Perinatol; 2011 Jun; 28(6):479-84. PubMed ID: 21225563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.